Literature DB >> 8137127

Neuropathology of spongiform encephalopathies in humans.

J E Bell1, J W Ironside.   

Abstract

The historical aspects and classification of human spongiform encephalopathies are reviewed and the newer concept of 'prion dementias' is explored. Guidelines for safe laboratory and autopsy handling of spongiform encephalopathy tissues are outlined: this includes an update on strategies which are currently thought to be effective in decontamination. A wide ranging review of the pathology of the various human spongiform encephalopathies includes newly emerging data on microglia, and cell-specific and neurodegenerative proteins. A large section of this chapter is devoted to the methodology of immunocytochemical demonstration of PrP in tissue sections, and the dilemmas inherent in interpretation. Clinicopathological correlations are provided for classical cases of spongiform encephalopathy, together with the newly recognised atypical dementias associated with PrP gene mutations. The pathology of iatrogenic cases of CJD is described. The chapter concludes with problems in differential diagnosis, and discussion of the histopathological features which help to resolve diagnostic dilemmas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8137127     DOI: 10.1093/oxfordjournals.bmb.a072645

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  17 in total

1.  Mapping the parameters of prion-induced neuropathology.

Authors:  M P Stumpf; D C Krakauer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  Creutzfeldt-Jakob disease in the elderly.

Authors:  R de Silva; C Findlay; I Awad; R Harries-Jones; R Knight; R Will
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  Creutzfeldt-Jakob disease in Canada. Laboratory Centre for Disease Control.

Authors: 
Journal:  Can Fam Physician       Date:  1996-11       Impact factor: 3.275

4.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain.

Authors:  M Haritani; Y I Spencer; G A Wells
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling.

Authors:  Wei Yang; Li-Feng Yang; Zhi-Qi Song; Syed Zahid Ali Shah; Yong-Yong Cui; Chao-Si Li; Hua-Fen Zhao; Hong-Li Gao; Xiang-Mei Zhou; De-Ming Zhao
Journal:  CNS Neurosci Ther       Date:  2017-03-14       Impact factor: 5.243

7.  Phospholipid composition of membranes directs prions down alternative aggregation pathways.

Authors:  Philip J Robinson; Teresa J T Pinheiro
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

8.  Creutzfeldt-Jakob disease in Austria.

Authors:  J A Hainfellner; K Jellinger; H Diringer; M Guentchev; R Kleinert; P Pilz; H Maier; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

9.  Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases.

Authors:  Grazia M Cereghetti; Arthur Schweiger; Rudi Glockshuber; Sabine Van Doorslaer
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

10.  Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.

Authors:  Mara Popović; Damjan Glavac; Sava Smerkolj; Viktor Svigelj; Gregor Kalan; Vesna Galvani; Maja Cernilec; Maja Bresjanac
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.